Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 553

Similar articles for PubMed (Select 9443730)

1.

Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.

Higashi K, Nishikawa T, Seki H, Oguchi M, Nambu Y, Ueda Y, Yuasa K, Tonami H, Okimura T, Yamamoto I.

J Nucl Med. 1998 Jan;39(1):9-15.

2.

IV. Masses in the mediastinum: primary mediastinal lymphoma and intermediate types.

Johnson PW.

Hematol Oncol. 2015 Jun;33 Suppl 1:29-32. doi: 10.1002/hon.2212. No abstract available.

PMID:
26062050
3.

Benefit of a second opinion: From metastatic disease to resectable lung cancer with sarcoid-like reaction.

Schook RM, Koudstaal L, Comans EF, Postmus PE, Grünberg K, Paul MA, Smit EF, Sutedja TG.

Respir Med Case Rep. 2014 Aug 12;13:26-7. doi: 10.1016/j.rmcr.2014.07.002. eCollection 2014.

4.

Radiolabeled Sugars used for PET and SPECT Imaging: Mini-Review.

Barrios-Lopez B, Bergstrom K.

Curr Radiopharm. 2015 May 24. [Epub ahead of print]

PMID:
26004636
5.

Comparison of autologous (111)In-leukocytes, (18)F-FDG, (11)C-methionine, (11)C-PK11195 and (68)Ga-citrate for diagnostic nuclear imaging in a juvenile porcine haematogenous staphylococcus aureus osteomyelitis model.

Nielsen OL, Afzelius P, Bender D, Schønheyder HC, Leifsson PS, Nielsen KM, Larsen JO, Jensen SB, Alstrup AK.

Am J Nucl Med Mol Imaging. 2015 Jan 15;5(2):169-82. eCollection 2015.

6.

[The role of PET in lung cancer staging].

Gärtner FC, Buermann J, Skowasch D, Biersack HJ, Essler M.

Dtsch Med Wochenschr. 2015 Apr;140(9):679-83. doi: 10.1055/s-0041-101521. Epub 2015 Apr 29. German.

PMID:
25924049
7.

Lung metastasis and pheochromocytomas: Detection using FDG PET/CT.

Hsu YL, Chang YC, Tu DG.

QJM. 2015 Apr 7. pii: hcv071. [Epub ahead of print] No abstract available.

PMID:
25852153
8.

Role of 64CuCl 2 PET/CT in staging of prostate cancer.

Capasso E, Durzu S, Piras S, Zandieh S, Knoll P, Haug A, Hacker M, Meleddu C, Mirzaei S.

Ann Nucl Med. 2015 Apr 2. [Epub ahead of print]

PMID:
25833290
9.

A strategy for improving FDG accumulation for early detection of metastasis from primary pancreatic cancer: stimulation of the Warburg effect in AsPC-1 cells.

Ogura M, Shikano N, Nakajima S, Sagara J, Yamaguchi N, Kusanagi K, Okui Y, Mizutani A, Kobayashi M, Kawai K.

Nucl Med Biol. 2015 May;42(5):475-81. doi: 10.1016/j.nucmedbio.2014.12.017. Epub 2015 Jan 8.

PMID:
25725984
10.

Grading meningioma: a comparative study of thallium-SPECT and FDG-PET.

Okuchi S, Okada T, Yamamoto A, Kanagaki M, Fushimi Y, Okada T, Yamauchi M, Kataoka M, Arakawa Y, Takahashi JC, Minamiguchi S, Miyamoto S, Togashi K.

Medicine (Baltimore). 2015 Feb;94(6):e549. doi: 10.1097/MD.0000000000000549.

PMID:
25674763
11.

Radiopharmaceuticals in nuclear medicine: recent developments for SPECT and PET studies.

Gutfilen B, Valentini G.

Biomed Res Int. 2014;2014:426892. doi: 10.1155/2014/426892. Epub 2014 Dec 21. No abstract available.

12.

Reduction of bladder activity on FDG PET/CT scan in patients with urinary bladder carcinoma. A prospective study with a patient-friendly protocol.

Tsai SC, Ou YC, Cheng CL, Li JR, Lin YC, Ho HC, Chiu KY, Su CK, Lin WY.

Nuklearmedizin. 2015;54(1):36-42. doi: 10.3413/Nukmed-0652-14-03. Epub 2014 Oct 27.

PMID:
25345433
13.

First clinical results of (D)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in patients with non-small cell lung cancer and head and neck squamous cell carcinoma.

Burger IA, Zitzmann-Kolbe S, Pruim J, Friebe M, Graham K, Stephens A, Dinkelborg L, Kowal K, Schibli R, Luurtsema G, Maas B, Horn-Tutic M, Haerle SK, Wiegers J, Schaefer NG, Hany TF, von Schulthess GK.

J Nucl Med. 2014 Nov;55(11):1778-85. doi: 10.2967/jnumed.114.140699. Epub 2014 Sep 25.

PMID:
25256060
14.

Use of pre-treatment 18F-FAMT PET to predict patient survival in squamous cell carcinoma of the esophagus treated by curative surgery.

Sohda M, Sakai M, Honjyo H, Hara K, Ozawa D, Suzuki S, Tanaka N, Yokobori T, Miyazaki T, Fukuchi M, Higuchi T, Tsushima Y, Kuwano H.

Anticancer Res. 2014 Jul;34(7):3623-8.

PMID:
24982378
15.

Imaging and modeling of flow in porous media using clinical nuclear emission tomography systems and computational fluid dynamics.

Boutchko R, Rayz VL, Vandehey NT, O'Neil JP, Budinger TF, Nico PS, Druhan JL, Saloner DA, Gullberg GT, Moses WW.

J Appl Geophy. 2012 Jan;76:74-81.

16.

The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma.

Lu P, Sun Y, Sun Y, Yu L.

Lung Cancer. 2014 Jul;85(1):53-8. doi: 10.1016/j.lungcan.2014.04.004. Epub 2014 Apr 18.

PMID:
24792334
17.

F-18 fluoro-deoxy-glucose and F-18 sodium fluoride cocktail PET/CT scan in patients with breast cancer having equivocal bone SPECT/CT.

Harisankar CN, Agrawal K, Bhattacharya A, Mittal BR.

Indian J Nucl Med. 2014 Apr;29(2):81-6. doi: 10.4103/0972-3919.130287.

18.

[(99)Tc(m)N-NOET dual-phase SPECT in differential diagnosis of benign and malignant lung tumors].

Liu H, Li S, Yang S, Wu Z.

Zhonghua Zhong Liu Za Zhi. 2014 Jan;36(1):48-52. Chinese.

PMID:
24685087
19.

A "dose on demand" Biomarker Generator for automated production of [(18)F]F(-) and [(18)F]FDG.

Awasthi V, Watson J, Gali H, Matlock G, McFarland A, Bailey J, Anzellotti A.

Appl Radiat Isot. 2014 Jul;89:167-75. doi: 10.1016/j.apradiso.2014.02.015. Epub 2014 Mar 6.

PMID:
24650573
20.

Quantitative volumetric CT-histogram analysis in N-staging of 18F-FDG-equivocal patients with lung cancer.

Flechsig P, Kratochwil C, Schwartz LH, Rath D, Moltz J, Antoch G, Heussel CP, Rieser M, Warth A, Zabeck H, Kauczor HU, Haberkorn U, Giesel FL.

J Nucl Med. 2014 Apr;55(4):559-64. doi: 10.2967/jnumed.113.128504. Epub 2014 Feb 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk